Home » Newsletters » BioWorld Asia

BioWorld Asia

May 26, 1999

View Archived Issues

TAB, Proteus Will Merge To Form #63M Company

Protein Discovery Could Lead To Oxygen-Sensing Answers

Evotec, Qiagen Form Venture For Nucleic Acid Systems

Chiroscience Finds Bone Gene With Osteoporosis Implications

BresaGens IPO Will Help Fund Work In Stem Cells

Phase II Trials Under Way For Xenovas XR9576 Drug

XTLs Trimera HBV Mouse Model Demonstrates Antiviral Efficacy

Israel Seeks European Partners

Oxford Biomedica Partners With Korean Gene Therapy Company

Biotech Salmon In The Pink

Celltech On Track To File U.S. NDA In Third Quarter

Alizyme Gets OK For Phase II On Renzapride

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...